Therefore, we used animal models to test whether there were intergroup differences in the expression level of MAPK3 in ovarian granulosa cells to explore whether BSTJF affected PCOS rats through related pathways (Figs. 4, 6). This evidence concerns the gene MAPK3 and polycystic ovary syndrome.